Market overview
The global robotic rehab tools market is worth USD 1.2 bn in 2026 and is forecast to reach USD 3.9 bn by 2036, growing at a 12.0% CAGR. United States is the largest country market and Exoskeletons is the largest by product segment.
| Scope | Powered robotic systems for physical therapy after stroke and spinal injury: wearable exoskeletons, robotic gait trainers, upper-limb robots and balance trainers used in hospitals, clinics and homes. |
|---|---|
| Industry | Healthcare |
| Value 2025 | USD 1.1 bn |
| Value 2026 | USD 1.2 bn |
| Value 2036 | USD 3.9 bn |
| CAGR 2026-2036 | 12.0% |
| Volume 2026 | 7,419 units |
| Volume 2036 | 25,479 units |
| Average price 2026 | USD 167,500 per unit |
| Report price | Starts from USD 1,999 |
| Published | November 2026 |
Request a free sample of this report
Robotic Rehab Tools market size and forecast, 2026-2036
Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.
| Year | Market value |
|---|---|
| 2026 | USD 1.2 bn |
| 2027 | USD 1.4 bn |
| 2028 | USD 1.6 bn |
| 2029 | USD 1.7 bn |
| 2030 | USD 2.0 bn |
| 2031 | USD 2.2 bn |
| 2032 | USD 2.5 bn |
| 2033 | USD 2.7 bn |
| 2034 | USD 3.1 bn |
| 2035 | USD 3.4 bn |
| 2036 | USD 3.9 bn |
Robotic Rehab Tools market segmentation
By product
Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.
| Segment | Share 2026 | Share 2036 | Value 2026 | CAGR 2026-36 |
|---|---|---|---|---|
| Exoskeletons | 30.0% | 37.2% | USD 373 mn | 14.4% |
| Gait and treadmill robots | 26.0% | 20.6% | USD 323 mn | 9.4% |
| Upper-limb robots | 24.0% | 24.9% | USD 298 mn | 12.4% |
| Balance and other trainers | 20.0% | 17.3% | USD 249 mn | 10.4% |
By end use
Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.
| Segment | Share 2026 | Share 2036 | Value 2026 | CAGR 2026-36 |
|---|---|---|---|---|
| Rehabilitation hospitals | 48.0% | 40.1% | USD 597 mn | 10.0% |
| Outpatient clinics | 30.0% | 30.0% | USD 373 mn | 12.0% |
| Home use | 22.0% | 29.9% | USD 273 mn | 15.5% |
By target body part
| Segment | Share 2026 | Share 2036 | Value 2026 | CAGR 2026-36 |
|---|---|---|---|---|
| Lower limb | 50.0% | 46.0% | USD 622 mn | 11.1% |
| Upper limb | 30.0% | 31.0% | USD 373 mn | 12.4% |
| Full body | 20.0% | 23.0% | USD 249 mn | 13.6% |
By mode
| Segment | Share 2026 | Share 2036 | Value 2026 | CAGR 2026-36 |
|---|---|---|---|---|
| Assistive | 44.0% | 42.0% | USD 547 mn | 11.5% |
| Resistive | 20.0% | 20.0% | USD 249 mn | 12.0% |
| Passive and mixed | 36.0% | 38.0% | USD 447 mn | 12.6% |
By patient
| Segment | Share 2026 | Share 2036 | Value 2026 | CAGR 2026-36 |
|---|---|---|---|---|
| Stroke | 38.0% | 36.0% | USD 472 mn | 11.4% |
| Spinal cord injury | 24.0% | 24.0% | USD 298 mn | 12.0% |
| Neurodegenerative | 18.0% | 20.0% | USD 224 mn | 13.2% |
| Orthopaedic and others | 20.0% | 20.0% | USD 249 mn | 12.0% |
Top 25 countries for robotic rehab tools by revenue
Countries are ranked by revenue earned from sales in the country, not by where the product is made. The ten largest hold 89.0% of 2026 revenue and the 25 countries below together hold 96.9%.
Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.
| # | Country | Value 2026 | Share 2026 | Value 2036 | CAGR 2026-36 |
|---|---|---|---|---|---|
| 1 | United States | USD 373 mn | 30.0% | USD 1.1 bn | 10.9% |
| 2 | China | USD 249 mn | 20.0% | USD 1.0 bn | 15.4% |
| 3 | Japan | USD 112 mn | 9.0% | USD 278 mn | 9.5% |
| 4 | Germany | USD 99 mn | 8.0% | USD 259 mn | 10.0% |
| 5 | South Korea | USD 62 mn | 5.0% | USD 201 mn | 12.4% |
| 6 | France | USD 50 mn | 4.0% | USD 135 mn | 10.5% |
| 7 | Italy | USD 50 mn | 4.0% | USD 135 mn | 10.5% |
| 8 | United Kingdom | USD 44 mn | 3.5% | USD 116 mn | 10.3% |
| 9 | Switzerland | USD 37 mn | 3.0% | USD 97 mn | 10.0% |
| 10 | India | USD 31 mn | 2.5% | USD 143 mn | 16.5% |
| 11 | United Arab Emirates | USD 22 mn | 1.8% | USD 80 mn | 13.8% |
| 12 | Spain | USD 13 mn | 1.1% | USD 33 mn | 9.8% |
| 13 | Netherlands | USD 9.6 mn | 0.8% | USD 25 mn | 9.9% |
| 14 | Brazil | USD 7.7 mn | 0.6% | USD 28 mn | 13.8% |
| 15 | Russia | USD 6.6 mn | 0.5% | USD 17 mn | 9.7% |
| 16 | Australia | USD 5.7 mn | 0.5% | USD 15 mn | 9.9% |
| 17 | Canada | USD 5.1 mn | 0.4% | USD 13 mn | 9.9% |
| 18 | Turkey | USD 4.6 mn | 0.4% | USD 17 mn | 13.7% |
| 19 | Poland | USD 4.2 mn | 0.3% | USD 15 mn | 13.8% |
| 20 | Belgium | USD 3.9 mn | 0.3% | USD 10 mn | 10.1% |
| 21 | Saudi Arabia | USD 3.6 mn | 0.3% | USD 13 mn | 13.8% |
| 22 | Taiwan | USD 3.4 mn | 0.3% | USD 8.5 mn | 9.7% |
| 23 | Sweden | USD 3.2 mn | 0.3% | USD 8.1 mn | 9.6% |
| 24 | Austria | USD 3.0 mn | 0.2% | USD 7.7 mn | 10.0% |
| 25 | Mexico | USD 2.9 mn | 0.2% | USD 10 mn | 13.8% |
| Rest of world | USD 38 mn | 3.1% | USD 102 mn | 10.2% |
Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.
Competitive landscape
Group 1: Global leaders
- DIH Holding
- Ekso Bionics
- Fourier Intelligence
- CYBERDYNE
- Bioness
Group 2: Regional and specialist players
- Lifeward
- Bionik Laboratories
- Myomo
- Wandercraft
- Ottobock
- Toyota Motor
- Human in Motion Robotics
- AlterG
- Gloreha
Group 3: Emerging and niche players
- Tyromotion
- Harmonic Bionics
- Neofect
- Motus Nova
- Siyi Intelligence
- ExoAtlet
Research methodology
Every figure on this page comes from the research framework that we apply to all of the markets we cover. The 2025 base for the robotic rehab tools market is built from the volume sold and the price that buyers pay, and is cross-checked against the size of the wider industry the market belongs to. Where a market can be sized in more than one way, the routes are compared before a figure is set.
The forecast runs year by year from the 2025 base to 2036. Growth in each year reflects demand from the industries that buy the product, adoption of new technology, pricing, regulation and replacement cycles. Volume and price are modelled together, so revenue in each year equals volume multiplied by average price. The 2026 to 2036 compound annual growth rate of 12.0% is calculated from the resulting values.
The market is divided by product, by end use, by target body part, by mode, by patient. The 25 largest countries are ranked by revenue earned from sales to buyers in each country, not by where the product is made. Segment values and country values add up to the market total in every year, and every report is checked for consistency before it is published.
Companies are placed in three groups: global leaders, regional and specialist players, and emerging and niche players. The groups describe how companies compete in the market. They are not a ranking and they are not market shares.
Our analysts also carry out primary research. Customized reports add interviews with key opinion leaders, such as senior executives, technical specialists and buyers, to test the assumptions behind the numbers for the question being asked.
Frequently asked questions
How big is the robotic rehab tools market?
The global robotic rehab tools market is estimated at USD 1.1 bn in 2025 and USD 1.2 bn in 2026.
How fast will the robotic rehab tools market grow?
It is forecast to reach USD 3.9 bn by 2036, a compound annual growth rate of 12.0% from 2026, an increase of USD 2.6 bn.
Which country is the largest market for robotic rehab tools?
United States is the largest market by revenue at USD 373 mn in 2026, 30.0% of the global total. The three largest countries together hold 59.0%.
Which country is growing fastest?
Among the ten largest markets, India is growing fastest at 16.5% a year from 2026 to 2036.
Which robotic rehab tools segment is largest?
In the by product split, Exoskeletons is the largest segment with 30.0% of 2026 revenue.
Who are the leading robotic rehab tools companies?
Global leaders include DIH Holding, Ekso Bionics, Fourier Intelligence, CYBERDYNE.
Need the full report?
Request a sample to see the structure, tables and country detail.
Request a free sampleRelated markets in Healthcare
- Advanced Implantable Electrode NeurotechnologyUSD 1.2 bn · 7.8% CAGR
- Manufacturing on Demand for MedicalUSD 1.2 bn · 10.0% CAGR
- Medical PendantUSD 1.3 bn · 6.0% CAGR
- AI-Accelerated Nonclinical Drug TestingUSD 1.2 bn · 14.0% CAGR
- Frozen Clinical MealUSD 1.3 bn · 3.8% CAGR
- Tablet PressUSD 1.2 bn · 5.5% CAGR
- Microwave Ablation DevicesUSD 1.2 bn · 9.5% CAGR
- AI-Driven Cardiac DiagnosticsUSD 1.3 bn · 16.0% CAGR